ATTENTION DEFICIT HYPERACTIVITY DISORDER: MODERN PRINCIPLES OF DIAGNOSTICS AND TREATMENT
https://doi.org/10.15690/vsp.v13i4.1084
Abstract
treatment terms must be not less than 4–6 months. The development and application of complex correction under ADHD should be carried out in due time and have individual character.
Keywords
About the Author
N. N. ZavadenkoRussian Federation
Zavadenko Nikolai Nikolaevich, PhD, professor, Head of the Department of Neurology, Neurosurgery and Clinical genetics of the Pediatric Faculty of Pirogov RNRMU
References
1. Young S., Fitzgerald M., Postma M. J. ADHD: making the invisible visible. An Expert White Paper on attention-deficit hyperactivity disorder (ADHD): policy solutions to address the societal impact, costs and long-term outcomes, in support of affected individuals. London. 2013. 26 p.
2. Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM–V). American Psychiatric Association. Washington. 2013. 947 p.
3. Barkley R. A. Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (3rd edn). New York: Guilford Press. 2005. 770 p.
4. Biederman J., Pettya C. R., Clarkea A., Lomedicoa A., Faraone S. V. Predictors of persistent ADHD: An 11-year Follow-up Study. J. Psychiatr. Res. 2011; 45 (2): 150–155.
5. Kooij S., Bejerot S., Blackwell A., Caci H., Casas-Brugue M., Carpentier P. J., Edvinsson D., Fayyad J., Foeken K., Fitzgerald M., Gaillac V., Ginsberg Y., Henry C., Krause J., Lensing M. B., Manor I., Niederhofer H., Nunes-Filipe C., Ohlmeier M. D., Oswald P., Pallanti S., Pehlivanidis A., Ramos-Quiroga J. A., Rastam M., RyffelRawak D., Stes S., Asherson P. European consensus statement on diagnosis and treatment of adult ADHD: The European Network. BMC Psychiatry. 2010; 10: 67.
6. Zavadenko N. N. Giperaktivnost’ i defitsit vnimaniya v detskom vozraste [Hyperactivity and Attention Deficit Disorder in Children]. Moscow, Akademiya, 2005. 256 p.
7. Bruce B., Kirkland S., Waschbusch D. The relationship between childhood behaviour disorders and unintentional injury events. Paediatrics & Child Health. 2007; 12 (9): 749–754.
8. MKB-10 — Mezhdunarodnaya klassifikatsiya boleznei (10-i peresmotr). Klassifikatsiya psikhicheskikh i povedencheskikh rasstroistv. Issledovatel’skie diagnosticheskie kriterii [ICD-10 — the International Statistical Classification of Diseases (10th revision). Classification of Mental and Behavioral Disorders. Research Diagnostic Criteria.]. St. Peteresburg, 1994. 208 p.
9. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (Revision). American Psychiatric Association. Washington. 2000. 943 p.
10. Goldstein S., Schwebach A. J. The comorbidity of pervasive developmental disorder and attention deficit hyperactvity disorder: results of a retrospective chart review. J. Autism Dev. Disord. 2004, 34 (3): 329–339.
11. Lee D. O., Ousley O. Y. Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. J. Child Adolesc. Psychopharmacol. 2006; 16: 737–746.
12. Simashkova N. V. Rasstroistva autisticheskogo spektra. Nauchno-prakticheskoe rukovodstvo [Autism Spectrum Disorders. Scientific and Practical Guidance]. Moscow, Avtorskaya Akademiya, 2013. 264 p.
13. Banaschewski T., Poustka L., Holtmann M. Autism and ADHD across the life span: differential diagnoses or comorbidity? Der Nervenarzt. 2011; 82 (5): 573–581.
14. Kotte A., Joshi G., Fried R., Uchida M., Spencer A., Wood worth K. Y., Kenworthy T., Faraone S. V., Biederman J. Autistic traits in children with and without ADHD. Pediatrics. 2013; 132 (3): 612–622.
15. Barkley R. A. Deti s vyzyvayushchim povedeniem. Klin. ruk-vo po obsledovaniyu rebenka i treningu roditelei. Per. s angl [Children with Attitude Problems. Clinical Guideline in Child Diagnosis and Parent Training. Translated from English]. Moscow, Terevinf, 2011. 272 p.
16. Altin M., El-Shafei A. A., Yu M., Desaiah D., Treuer T., Zava denko N. N., Gao H. Y. Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries. Drugs in Context. J. Inter ventions Clin. Pract. 2013; 212–260: 1–12. Doi: 10.7573/dic.212260 www.drugsincontext.com (open access).
17. Riley A. W., Forrest C. B., Starfield B., Rebok G. W., Robertson J. A., Green B. F. The parent report form of the CHIP-child edition: reliability and validity. Med. Care. 2004; 42: 210–220.
18. Zavadenko N. N., Suvorinova N.Yu. Zhurn. nevrol. i psikhiatrii im. S. S. Korsakova — S. S. Korsakov journal of neorology and psychiatry. 2011; 111 (10): 28–32.
19. DuPaul G. J., Power T. J., Anastopoulos A. D., Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretations. New York: Guilford. 1998. 80 p. 20. Weiss M. D., Wasdell M. B., Bomben M. M. Weiss functional impairment rating scale — parent report (WFIRS-P). BC Children’s Hospital. 2004. 10 p.
Review
For citations:
Zavadenko N.N. ATTENTION DEFICIT HYPERACTIVITY DISORDER: MODERN PRINCIPLES OF DIAGNOSTICS AND TREATMENT. Current Pediatrics. 2014;13(4):48-53. (In Russ.) https://doi.org/10.15690/vsp.v13i4.1084